Equillium, Inc.

United States · 58 Employees
Equillium is a clinical-stage biotechnology company leveraging deep understanding of immunobiology to pioneer new products with a mission to dramatically improve the lives of patients with severe autoimmune and inflammatory diseases who continue to suffer with high unmet medical needs. By bringing treatments designed to restore the balance of the immune system, we hope to restore the balance of life for patients in need. Our lead product candidate, itolizumab, is a first-in-class monoclonal antibody that targets the CD6-ALCAM signaling pathway, which plays a central role in the activation and trafficking of pathogenic effector T cells that drive inflammation in a number of diseases. We believe itolizumab may have broad therapeutic utility and our current pipeline is focused on developing itolizumab as a best-in-class treatment for multiple severe immuno-inflammatory disorders – this includes acute graft-versus-host disease, SLE / lupus nephritis and uncontrolled asthma.

概述

国家 United States
成立时间 2017
总部 2223 avenida de la playa, san diego, california, united states
电话号码 +1 858-412-5302
网站 http://www.equilliumbio.com
LinkedIn http://www.linkedin.com/company/equillium
Twitter https://twitter.com/bionizt
Facebook https://facebook.com/BionizTherapeutics/
员工数 58
行业 research,
简介 Equillium is a clinical-stage biotechnology company leveraging deep understanding of immunobiology to pioneer new products with a mission to dramatically improve the lives of patients with severe autoimmune and inflammatory diseases who continue to suffer with high unmet medical needs. By bringing treatments designed to restore the balance of the immune system, we hope to restore the balance of life for patients in need. Our lead product candidate, itolizumab, is a first-in-class monoclonal antibody that targets the CD6-ALCAM signaling pathway, which plays a central role in the activation and trafficking of pathogenic effector T cells that drive inflammation in a number of diseases. We believe itolizumab may have broad therapeutic utility and our current pipeline is focused on developing itolizumab as a best-in-class treatment for multiple severe immuno-inflammatory disorders – this includes acute graft-versus-host disease, SLE / lupus nephritis and uncontrolled asthma.

技术

Amazon AWS

Hosting

BugHerd

Widgets

CloudFlare Hosting

Hosting

Google Analytics

Analytics and Tracking

Google Font API

Fonts

Google Tag Manager

Tag Management

MailJet

Email Delivery

Mobile Friendly

Other

New Relic

Web Performance Monitoring

Nginx

Load Balancers

Outlook

Email Providers

WordPress.org

CMS

reCAPTCHA

Captcha

常见问题

Equillium, Inc. 在哪里?

Equillium, Inc. 的总部位于 2223 avenida de la playa, san diego, california, united states

Equillium, Inc. 的电话号码是多少?

Equillium, Inc. 的电话号码是 +1 858-412-5302

Equillium, Inc. 的官方网站是什么?

Equillium, Inc. 的公司官方网站是 http://www.equilliumbio.com

Equillium, Inc. 是做什么的?

Equillium, Inc. 的业务有哪些?

Equillium, Inc. 的年收入是多少?

Equillium, Inc. 的收入是 4500000美元

Equillium, Inc. 有多少员工?

Equillium, Inc. 有 58 名员工

Equillium, Inc. 属于哪个行业?

Equillium, Inc. 从事以下行业: research

Equillium, Inc. 使用什么技术?

Equillium, Inc. 使用的一些流行技术包括: Amazon AWS,BugHerd,CloudFlare Hosting,Google Analytics,Google Font API,Google Tag Manager,MailJet,Mobile Friendly,New Relic,Nginx,Outlook,WordPress.org,reCAPTCHA

如何联系 Equillium, Inc.?

Equillium, Inc. 联系信息: 电话号码:+1 858-412-5302, 网站:http://www.equilliumbio.com, 邮箱:jfa***@***.com

Equillium, Inc. 的社交媒体链接是什么?

Equillium, Inc. 领英:http://www.linkedin.com/company/equillium,fackbook:https://facebook.com/BionizTherapeutics/,twitte:https://twitter.com/bionizt

Equillium, Inc. 是一家上市公司吗?

是的,Equillium, Inc.是一家上市公司,在nasdaq公开挂牌上市,上市交易代码:EQ

Equillium, Inc. 的最后一轮融资是什么时候?

暂无最近投资信息

谁投资 Equillium, Inc.?

Equillium, Inc. 有 0 家投资者,包括 。

管理层

Jessica Faria

Senior Director, Drug Safety and Pharmacovigilance Operations

Bethany H

Executive Manager

Lara Rose

Clinical Trial Manager

Catherine

Vice President Clinical Operations

员工

Jack Bukowski

Biopharmaceutical Consultant

Laura Brown

Accounts Payable Specialist

Mena Popal

Clinical Trial Associate

Brooke Davis

Clinical Research Associate

Monika Nowosiad-Magda

Clinical Development Medical Consultant

外贸获客 查找关键决策人

10亿+海关交易数据,1.2亿企业数据,2亿+企业联系人数据,1000千万真实采购商。覆盖200+个国家及地区,95%外贸重点拓展市场,可根据行业、经营范围等多方位挖掘目标客户。
免费试用

Top-ranked on G2 Crowd

全球B2B企业库 海关贸易数据 展会采购数据

工作更少,成就更大,销售更聪明

查找更多 B2B 联系人,丰富并验证记录
Email Address

全球B2B企业库

海关贸易数据

展会采购数据

Top-ranked on G2 Crowd

OR
Sign Up with Google